Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This trial is conducted in Asia. The aim of this trial is to compare the efficacy of postprandial plasma glucose of two treatment regimens in Chinese subjects.
Interventions
Sponsors
Novo Nordisk A/S
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Type 1 or 2 diabetes for at least 4 weeks * Treatment with oral antidiabetic drugs (OADs) and/or insulin for at least 4 weeks * HbA1c: 7.5-13.5% * Body Mass Index (BMI): 18-35 kg/m2
Exclusion criteria
* Treatment with either soluble human insulin or insulin NPH three times daily within 3 months before trial participation * History of drug abuse or alcohol dependence
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-hours postprandial plasma glucose (PPPG) | after 12 weeks of treatment |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of subjects achieving 2-hours PPPG treatment target | — |
| Percentage of subjects achieving HbA1c treatment target | — |
| HbA1c | — |
| Fasting plasma glucose | — |
| Hypoglycaemic episodes | — |
Countries
China
Outcome results
None listed